DE69507493T2 - Tirilazad parentale formulierung mit einem co-lösungsmittel - Google Patents
Tirilazad parentale formulierung mit einem co-lösungsmittelInfo
- Publication number
- DE69507493T2 DE69507493T2 DE69507493T DE69507493T DE69507493T2 DE 69507493 T2 DE69507493 T2 DE 69507493T2 DE 69507493 T DE69507493 T DE 69507493T DE 69507493 T DE69507493 T DE 69507493T DE 69507493 T2 DE69507493 T2 DE 69507493T2
- Authority
- DE
- Germany
- Prior art keywords
- pct
- tirilazad
- solvent
- sec
- parental formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29937094A | 1994-09-01 | 1994-09-01 | |
US38225695A | 1995-02-01 | 1995-02-01 | |
PCT/US1995/010730 WO1996006618A1 (en) | 1994-09-01 | 1995-08-29 | Cosolvent parenteral formulation of tirilazad |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69507493D1 DE69507493D1 (de) | 1999-03-04 |
DE69507493T2 true DE69507493T2 (de) | 1999-06-10 |
Family
ID=26971187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69507493T Expired - Fee Related DE69507493T2 (de) | 1994-09-01 | 1995-08-29 | Tirilazad parentale formulierung mit einem co-lösungsmittel |
Country Status (23)
Country | Link |
---|---|
US (1) | US5858999A (de) |
EP (1) | EP0778775B1 (de) |
JP (1) | JPH10505063A (de) |
KR (1) | KR100359556B1 (de) |
CN (1) | CN1156962A (de) |
AT (1) | ATE175875T1 (de) |
AU (1) | AU696856B2 (de) |
BR (1) | BR9508655A (de) |
CA (1) | CA2196063A1 (de) |
CZ (1) | CZ283875B6 (de) |
DE (1) | DE69507493T2 (de) |
DK (1) | DK0778775T3 (de) |
ES (1) | ES2128761T3 (de) |
FI (1) | FI970858A (de) |
GR (1) | GR3029396T3 (de) |
HU (1) | HUT76808A (de) |
MX (1) | MX9701342A (de) |
NO (1) | NO311405B1 (de) |
NZ (1) | NZ292690A (de) |
PL (1) | PL181244B1 (de) |
RU (1) | RU2152789C2 (de) |
SK (1) | SK280278B6 (de) |
WO (1) | WO1996006618A1 (de) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6254564B1 (en) | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
US6017948A (en) * | 1998-10-30 | 2000-01-25 | Supergen, Inc. | Water-miscible pharmaceutical compositions |
EP1143962B1 (de) * | 1999-01-28 | 2004-11-24 | Dinesh Shantilal Patel | Parenterale lösungen enthaltend propofol (2,6-diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6-dianhydro-d-glucitol als lösungsmittel |
DE10010073B4 (de) | 2000-02-28 | 2005-12-22 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verankerung für implantierbare Herzklappenprothesen |
DE10010074B4 (de) | 2000-02-28 | 2005-04-14 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Vorrichtung zur Befestigung und Verankerung von Herzklappenprothesen |
FR2828263B1 (fr) | 2001-08-03 | 2007-05-11 | Philipp Bonhoeffer | Dispositif d'implantation d'un implant et procede d'implantation du dispositif |
US20040058895A1 (en) * | 2002-09-18 | 2004-03-25 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
US20040053895A1 (en) * | 2002-09-18 | 2004-03-18 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
AU2004304716B2 (en) * | 2003-12-18 | 2010-05-27 | Biomas Ltd. | Tellurium derivatives for prevention and treatment of neurodegenerative processes |
EP1796660B1 (de) | 2004-09-17 | 2016-11-23 | BioMAS Ltd. | Verwendung von ammonium trichloro(dioxyethylene-o,o')tellurat (as101) zur hemmung des interleukin-1beta-umwandelden enzyms |
US20070014719A1 (en) * | 2004-09-29 | 2007-01-18 | Reading Christopher L | Steroid analogs and characterization and treatment methods |
DE102005003632A1 (de) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Katheter für die transvaskuläre Implantation von Herzklappenprothesen |
DE102005051849B4 (de) | 2005-10-28 | 2010-01-21 | JenaValve Technology Inc., Wilmington | Vorrichtung zur Implantation und Befestigung von Herzklappenprothesen |
DE102005052628B4 (de) | 2005-11-04 | 2014-06-05 | Jenavalve Technology Inc. | Selbstexpandierendes, flexibles Drahtgeflecht mit integrierter Klappenprothese für den transvaskulären Herzklappenersatz und ein System mit einer solchen Vorrichtung und einem Einführkatheter |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US9138315B2 (en) | 2007-04-13 | 2015-09-22 | Jenavalve Technology Gmbh | Medical device for treating a heart valve insufficiency or stenosis |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
JP5220101B2 (ja) | 2007-05-15 | 2013-06-26 | イエナバルブ テクノロジー インク | 自己拡張型の心臓弁ステントを挿入するためにカテーテル先端、カテーテルシステムおよび医療挿入システムを操作するためのハンドル |
US8398704B2 (en) | 2008-02-26 | 2013-03-19 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
BR112012021347A2 (pt) | 2008-02-26 | 2019-09-24 | Jenavalve Tecnology Inc | stent para posicionamento e ancoragem de uma prótese valvular em um local de implantação no coração de um paciente |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
US9168130B2 (en) | 2008-02-26 | 2015-10-27 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US8465540B2 (en) | 2008-02-26 | 2013-06-18 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis |
US8317858B2 (en) | 2008-02-26 | 2012-11-27 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
SI2805720T1 (sl) | 2008-05-28 | 2019-11-29 | Reveragen Biopharma Inc | Ne-hormonski steroidni modulatorji NF-KB za zdravljenje bolezni |
US20100292779A1 (en) | 2009-05-15 | 2010-11-18 | Helmut Straubinger | Device for compressing a stent and a system as well as a method for loading a stent into a medical delivery system |
US9198921B2 (en) | 2010-04-05 | 2015-12-01 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
US11278406B2 (en) | 2010-05-20 | 2022-03-22 | Jenavalve Technology, Inc. | Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect |
US10856978B2 (en) | 2010-05-20 | 2020-12-08 | Jenavalve Technology, Inc. | Catheter system |
AU2011257298B2 (en) | 2010-05-25 | 2014-07-31 | Jenavalve Technology Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
CA2852369A1 (en) | 2011-10-21 | 2013-04-25 | Jenavalve Technology Inc. | Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect |
WO2013171007A1 (en) | 2012-05-16 | 2013-11-21 | Jenavalve Technology Gmbh | Catheter delivery system for introducing an expandable heart valve prosthesis and medical device for the treatment of a heart valve defect |
CN103861090B (zh) * | 2012-12-18 | 2017-06-13 | 美迪思生物科技(北京)有限公司 | 含蛋白或多肽的疏水溶液、其制备方法及用途 |
EP4098226A1 (de) | 2013-08-30 | 2022-12-07 | JenaValve Technology, Inc. | Endoprothese mit einem radial zusammenklappbaren rahmen und einer klappenprothese |
EP3288495B1 (de) | 2015-05-01 | 2019-09-25 | JenaValve Technology, Inc. | Vorrichtung mit reduzierter herzschrittmacherrate bei herzklappenersatz |
US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
EP3454795B1 (de) | 2016-05-13 | 2023-01-11 | JenaValve Technology, Inc. | Herzklappenprotheseneinführungssystem zur einführung einer herzklappenprothese mit einführerhülse und ladesystem |
WO2018138658A1 (en) | 2017-01-27 | 2018-08-02 | Jenavalve Technology, Inc. | Heart valve mimicry |
US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3580140D1 (de) * | 1984-03-14 | 1990-11-22 | Jerome Corbiere | Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel. |
US5175281A (en) * | 1985-09-12 | 1992-12-29 | The Upjohn Company | Pharmaceutically active pyrimidinylpiperazinylsterioids |
WO1987001706A2 (en) * | 1985-09-12 | 1987-03-26 | The Upjohn Company | C20 through c26 amino steroids |
US4968675A (en) * | 1988-10-28 | 1990-11-06 | Upjohn | Non-hemolytic lazaroid parenteral formulation |
US5124154A (en) * | 1990-06-12 | 1992-06-23 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
JP2002500616A (ja) * | 1994-07-21 | 2002-01-08 | ファルマシア・アンド・アップジョン・カンパニー | 神経学的に活性なアミノステロイド |
US5614515A (en) * | 1994-11-17 | 1997-03-25 | University Of Southern California | Lazaroid-based compositions and method for preventing adhesion formation using the same |
-
1995
- 1995-08-29 WO PCT/US1995/010730 patent/WO1996006618A1/en active IP Right Grant
- 1995-08-29 EP EP95931566A patent/EP0778775B1/de not_active Expired - Lifetime
- 1995-08-29 ES ES95931566T patent/ES2128761T3/es not_active Expired - Lifetime
- 1995-08-29 PL PL95318901A patent/PL181244B1/pl not_active IP Right Cessation
- 1995-08-29 KR KR1019970701344A patent/KR100359556B1/ko not_active IP Right Cessation
- 1995-08-29 SK SK262-97A patent/SK280278B6/sk unknown
- 1995-08-29 BR BR9508655A patent/BR9508655A/pt not_active IP Right Cessation
- 1995-08-29 CZ CZ97559A patent/CZ283875B6/cs not_active IP Right Cessation
- 1995-08-29 MX MX9701342A patent/MX9701342A/es unknown
- 1995-08-29 RU RU97105066/14A patent/RU2152789C2/ru not_active IP Right Cessation
- 1995-08-29 NZ NZ292690A patent/NZ292690A/en unknown
- 1995-08-29 CA CA002196063A patent/CA2196063A1/en not_active Abandoned
- 1995-08-29 JP JP8508842A patent/JPH10505063A/ja not_active Withdrawn
- 1995-08-29 US US08/875,217 patent/US5858999A/en not_active Expired - Fee Related
- 1995-08-29 DE DE69507493T patent/DE69507493T2/de not_active Expired - Fee Related
- 1995-08-29 AU AU34938/95A patent/AU696856B2/en not_active Ceased
- 1995-08-29 DK DK95931566T patent/DK0778775T3/da active
- 1995-08-29 HU HU9701255A patent/HUT76808A/hu unknown
- 1995-08-29 CN CN95194876A patent/CN1156962A/zh active Pending
- 1995-08-29 AT AT95931566T patent/ATE175875T1/de not_active IP Right Cessation
-
1997
- 1997-02-28 NO NO19970935A patent/NO311405B1/no unknown
- 1997-02-28 FI FI970858A patent/FI970858A/fi not_active IP Right Cessation
-
1999
- 1999-02-12 GR GR990400480T patent/GR3029396T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
RU2152789C2 (ru) | 2000-07-20 |
GR3029396T3 (en) | 1999-05-28 |
MX9701342A (es) | 1997-05-31 |
DE69507493D1 (de) | 1999-03-04 |
CZ283875B6 (cs) | 1998-06-17 |
WO1996006618A1 (en) | 1996-03-07 |
BR9508655A (pt) | 1997-08-12 |
DK0778775T3 (da) | 1999-09-13 |
NO970935D0 (no) | 1997-02-28 |
CA2196063A1 (en) | 1996-03-07 |
FI970858A0 (fi) | 1997-02-28 |
HUT76808A (en) | 1997-11-28 |
ES2128761T3 (es) | 1999-05-16 |
AU696856B2 (en) | 1998-09-17 |
EP0778775B1 (de) | 1999-01-20 |
PL318901A1 (en) | 1997-07-21 |
JPH10505063A (ja) | 1998-05-19 |
SK26297A3 (en) | 1997-09-10 |
NZ292690A (en) | 1998-06-26 |
US5858999A (en) | 1999-01-12 |
ATE175875T1 (de) | 1999-02-15 |
SK280278B6 (sk) | 1999-10-08 |
AU3493895A (en) | 1996-03-22 |
CZ55997A3 (en) | 1997-06-11 |
EP0778775A1 (de) | 1997-06-18 |
NO311405B1 (no) | 2001-11-26 |
PL181244B1 (pl) | 2001-06-29 |
NO970935L (no) | 1997-04-11 |
FI970858A (fi) | 1997-02-28 |
KR100359556B1 (ko) | 2002-12-18 |
CN1156962A (zh) | 1997-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69507493D1 (de) | Tirilazad parentale formulierung mit einem co-lösungsmittel | |
SE9503143D0 (sv) | New preparation | |
ATE113839T1 (de) | Arzneimittel gegen impotenz. | |
LU90736I2 (fr) | Agenerase-amprenavir et ses d-riv-s pharmaceutiquement acceptables | |
GR3017282T3 (en) | Novel arylpyridazines, their manufacture, use and medicaments containing them. | |
ITRM920876A0 (it) | Procedimento per la duplicazione o la realizzazione di una copia di una protesi dentaria e prodotto cosi' ottenuto. | |
ITMI921569A1 (it) | N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica, dopaminergica e adrenergica | |
IT1236133B (it) | Metodo e dispositivo per l'agugliatura di un nastro di ovatta su un nastro di sopporto scorrevole senza fine. | |
FR2687401B1 (fr) | Derives de la 1,4-dialkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant. | |
ES2062137T3 (es) | Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea. | |
SE9402880D0 (sv) | New peptide derivatives | |
YU5893A (sh) | Sulfonilkarbamid i postupak za njegovo dobijanje | |
HUP9600498A3 (en) | Antimigrane 1,2,5-thiadiazole derivatives of 1-indolylalkyl-4-pyridinyl and -4-pyrimidinylpiperazines and pharmaceutical compositions containing the same | |
IT1297715B1 (it) | Procedimento e dispositivo per l'agugliatura di un nastro di ovatta. | |
FR2713069B1 (fr) | Dispositif d'épluchage d'épices et notamment d'ail. | |
FR2710539B1 (fr) | Ensemble d'aiguille chirurgicale. | |
FR2734822B1 (fr) | Nouveaux derives du 2-azabicyclo(2.2.1)heptane, leur preparation et leur application | |
DE69307894T2 (de) | Ng-monomethyl-l-arginin-hydrochlorid-derivate und verfahren zu deren herstellung | |
HK1029277A1 (en) | Pharmaceutical coating composition and method of use. | |
NZ319746A (en) | A synergisitic combination of a beta-receptor blocker and an opioid | |
SE9500897D0 (sv) | The pharmacological use of certain cystine derivatives | |
BR9712628A (pt) | Derivados de 8(9)-deidroestradiol | |
GB9517758D0 (en) | Compositions and their uses | |
SE8900906D0 (sv) | Hopfaellbar tandborste | |
RU93042104A (ru) | Противокашлевая композиция, содержащая декстрометорфан, способ ее применения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |